Simon Jones: Reasons to be cheerful

You might remember a slightly pessimistic leader column a couple of weeks ago following the news about the results of the Pfizer vaccine trials. The same concerns regarding storage logistics and availability (in the UK, at least) still exist, but the overall vaccine picture has improved in the past week or so, and there might now be some reasons to be cheerful.

Positive results from interim analysis of the Oxford University/AstraZeneca mean we now have a clearer picture of how the vaccination rollout could be managed, along with potential timeframes for the most vulnerable and most important frontline health workers to receive the jabs.